B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signal attenuation

REACTOME PATHWAY
Reactome: R-HSA-747495 genes31 compounds

The Signal attenuation pathway (Reactome ID: R-HSA-74749) involves 5 genes and is affected by 31 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

GRB2INSINSRMAPK1MAPK3

Compounds Affecting Signal attenuation

#CompoundTargets HitStudies
1Sorafenib300
2plumbagin [Supplementary Concept]300
3pd980597
4alsterpaullone12
5kenpaullone8
6sp600125117
7isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
8trametinib296
9withaferin300
10tyrphostin ag 14784
11Clotrimazole296
12fisetin78
13Progesterone299
142-Chloroadenosine 2-Chloroadenosine.300
15Benzalkonium Compounds299
16Calcimycin216
17daph2
18Diphenhydramine14
19ha10044
20Lithocholic Acid300
21Loratadine296
22trequinsin hydrochloride1
23Crizotinib298
24Apigenin 5,7,4'-trihydroxy-flavone,300
25myricetin-3-O-galactopyranoside [Supplementary Concept]300
26Digitoxin300
27Digoxin299
28Flutamide298
29m0842
30Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against299
31Dactinomycin297

About the Signal attenuation Pathway

The Signal attenuation pathway is catalogued in Reactome (ID: R-HSA-74749) and involves 5 genes. In the BiohacksAI corpus, 31 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include GRB2, INS, INSR, MAPK1, MAPK3.